ResearcherUniversity of Wisconsin–MadisonNo recent work listed
Reinier T. Hernandez
Matched on ORCID iD 0000-0002-0729-2179; OpenAlex author ID A5075107380. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2016: 3 papers · 2017: 1 paper
Papers 4
- ImmunoPET imaging of tissue factor expression in pancreatic cancer with 89Zr-Df-ALT-836. Co-author DOI 10.1016/j.jconrel.2017.08.029↗
- Molecular Imaging of Pancreatic Cancer with Antibodies. First author DOI 10.1021/acs.molpharmaceut.5b00626↗
- ImmunoPET Imaging of Insulin-Like Growth Factor 1 Receptor in a Subcutaneous Mouse Model of Pancreatic Cancer. Co-author DOI 10.1021/acs.molpharmaceut.6b00132↗
- Dual Targeting of Tissue Factor and CD105 for Preclinical PET Imaging of Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-15-2054↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Christopher G. England · 4 shared papers, 2016–2017 · strength 0.27
- Paper Molecular Imaging of Pancreatic Cancer with Antibodies. DOI 10.1021/acs.molpharmaceut.5b00626↗
- Paper ImmunoPET imaging of tissue factor expression in pancreatic cancer with 89Zr-Df-ALT-836. DOI 10.1016/j.jconrel.2017.08.029↗
- Paper Dual Targeting of Tissue Factor and CD105 for Preclinical PET Imaging of Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-15-2054↗
- Weibo Cai · 4 shared papers, 2016–2017 · strength 0.27
- Paper Molecular Imaging of Pancreatic Cancer with Antibodies. DOI 10.1021/acs.molpharmaceut.5b00626↗
- Paper ImmunoPET imaging of tissue factor expression in pancreatic cancer with 89Zr-Df-ALT-836. DOI 10.1016/j.jconrel.2017.08.029↗
- Paper Dual Targeting of Tissue Factor and CD105 for Preclinical PET Imaging of Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-15-2054↗
- Haiming Luo · 1 shared paper, 2016 · strength 0.06
- Hyung‐Jun Im · 1 shared paper, 2016 · strength 0.05
- Dong Soo Lee · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.